Penumbra Cash Flow Statement
NYSE: PENHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Penumbra free cash flow
In fiscal 2025, Penumbra generated $238.7 million of operating cash flow and spent $63.7 million on capital expenditures. That left free cash flow of $174.9 million, a free-cash-flow margin of 12.5% of revenue. Free cash flow was up 18.8% from the prior year's $147.3 million.
Summary generated from market data by MetaCap's automated system. Methodology
Penumbra cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 177.69M | 14.01M | 90.95M | -2.00M | 2.62M | -19.26M | 47.00M | 2.91M | 4.66M | 14.81M |
| Net Income growth (YoY) | +1168.11% | -84.59% | — | -176.32% | — | -140.97% | +1515.26% | -37.51% | -68.56% | +526.38% |
| Depreciation & Amortization | 17.47M | 23.70M | 27.26M | 24.32M | 16.41M | 12.89M | 8.10M | 6.17M | 3.78M | 2.30M |
| Stock-Based Compensation | 59.21M | 46.16M | 50.52M | 37.38M | 65.76M | 25.54M | 21.48M | 18.42M | 17.81M | 14.64M |
| Change in Working Capital | -55.63M | -37.84M | -85.79M | -132.34M | -87.50M | -74.45M | -64.40M | -44.49M | -23.66M | -41.97M |
| Operating Cash Flow | 238.66M | 168.48M | 97.33M | -55.66M | 9.50M | -33.24M | 26.65M | 28.81M | 12.69M | -12.81M |
| Capital Expenditures | -63.73M | -21.18M | -15.21M | -19.30M | -21.18M | -24.76M | -22.11M | -9.60M | -12.53M | -13.63M |
| Investing Cash Flow | -404.59M | 77.62M | -16.08M | 54.79M | -21.73M | -104.15M | -12.71M | -385.00K | -77.65M | 687.00K |
| Share Repurchases | 0 | -100.39M | 0 | 0 | — | — | — | — | — | — |
| Financing Cash Flow | 26.53M | -87.01M | 16.20M | 11.62M | 836.00K | 134.92M | -8.96M | -9.81M | 104.36M | 7.13M |
| Net Change in Cash | -137.51M | 156.92M | 97.63M | 10.48M | -10.29M | -3.11M | 4.93M | 17.21M | 37.40M | -6.31M |
| Free Cash Flow | 174.93M | 147.30M | 82.12M | -74.96M | -11.68M | -58.00M | 4.54M | 19.20M | 159.00K | -26.44M |
This table shows 10 annual periods of Penumbra's cash flow statement, from FY 2025 back to FY 2016, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PEN's reporting calendar. What is a cash flow statement?